Combination of 0.09% cyclosporine and intense pulsed light (IPL) therapy for the treatment of dry eye disease in symptomatic contact lens wearers: study protocol for a sham-controlled randomized clinical trial.

Lortie-Milner E, Michaud L, Dubois MF, Boissy P

Open source

DOI
10.1186/s13063-026-09521-w
Published
2026 Feb 7
Container
Trials
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-026-09521-w,
  title = {Combination of 0.09\% cyclosporine and intense pulsed light (IPL) therapy for the treatment of dry eye disease in symptomatic contact lens wearers: study protocol for a sham-controlled randomized clinical trial.},
  author = {Lortie-Milner E and Michaud L and Dubois MF and Boissy P},
  year = {2026},
  journal = {Trials},
  doi = {10.1186/s13063-026-09521-w},
  url = {https://doi.org/10.1186/s13063-026-09521-w}
}

RIS

TY  - JOUR
TI  - Combination of 0.09% cyclosporine and intense pulsed light (IPL) therapy for the treatment of dry eye disease in symptomatic contact lens wearers: study protocol for a sham-controlled randomized clinical trial.
AU  - Lortie-Milner E
AU  - Michaud L
AU  - Dubois MF
AU  - Boissy P
PY  - 2026
JO  - Trials
DO  - 10.1186/s13063-026-09521-w
UR  - https://doi.org/10.1186/s13063-026-09521-w
ER  - 

APA

E, L., L, M., MF, D., & P, B. (2026). Combination of 0.09% cyclosporine and intense pulsed light (IPL) therapy for the treatment of dry eye disease in symptomatic contact lens wearers: study protocol for a sham-controlled randomized clinical trial.. Trials. https://doi.org/10.1186/s13063-026-09521-w

Source records